Caterina Frati Selected Research

human KAT2A protein

1/2022

GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Frati Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 01/2010
4	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2015
3	Heart Diseases (Heart Disease) 01/2022 - 12/2020
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 01/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 12/2014
3	Myocardial Infarction 01/2016 - 03/2011
2	Heart Failure 01/2022 - 01/2015
2	Fibrosis (Cirrhosis) 01/2021 - 03/2011
2	Adenocarcinoma 01/2018 - 12/2014
2	Cardiotoxicity 01/2015 - 03/2013
1	Pleural Effusion (Pleural Effusions) 02/2022
1	Malignant Mesothelioma 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2020
1	Breast Neoplasms (Breast Cancer) 04/2020
1	Noncommunicable Diseases 01/2019
1	Carcinoma (Carcinomatosis) 01/2016
1	Circulating Neoplastic Cells 01/2015
1	Carcinogenesis 12/2014
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2013
1	Hyperglycemia 01/2012
1	Ventricular Dysfunction 01/2012
1	Ventricular Remodeling 01/2012
1	Infarction (Infarctions) 03/2011
1	Hypertrophy 03/2011

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 02/2022 - 01/2010
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016 - 03/2011
3	AnthracyclinesIBA 01/2015 - 01/2010
2	ferric oxide (iron oxide)IBA 08/2021 - 12/2020
2	CalciumIBA 09/2020 - 01/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2016 - 09/2015
2	Insulin (Novolin)FDA Link 09/2015 - 03/2011
2	ResveratrolIBA 01/2015 - 01/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 03/2013
1	lorlatinibIBA 02/2022
1	brigatinibIBA 02/2022
1	EnzymesIBA 01/2022
1	LipidsIBA 01/2022
1	human KAT2A proteinIBA 01/2022
1	AsbestosIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Adenosine Triphosphate (ATP)IBA 04/2020
1	multidrug resistance-associated protein 1IBA 04/2020
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2020
1	Biological FactorsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	B7-H1 AntigenIBA 01/2018
1	NivolumabIBA 01/2018
1	SuspensionsIBA 01/2016
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2016
1	CrizotinibIBA 11/2015
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 09/2015
1	AlpelisibIBA 08/2015
1	Pharmaceutical PreparationsIBA 08/2015
1	Class I Phosphatidylinositol 3-KinasesIBA 08/2015
1	Sirtuin 1IBA 01/2015
1	Epithelial Cell Adhesion MoleculeIBA 01/2015
1	AntigensIBA 01/2015
1	Conditioned Culture MediaIBA 12/2014
1	Thyroid Nuclear Factor 1IBA 12/2014
1	Transcription Factor 3IBA 12/2014
1	Keratins (Keratin)IBA 12/2014
1	Octamer Transcription FactorsIBA 12/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2011
1	Connexin 43 (Connexin43)IBA 03/2011
1	CytokinesIBA 03/2011
1	Cadherins (E-Cadherin)IBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	Bromodeoxyuridine (BrdU)IBA 03/2011

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2010
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
2	Immunotherapy 08/2020 - 01/2018
1	Microspheres (Microsphere) 01/2021
1	Bioreactors (Bioreactor) 01/2016
1	Aftercare (After-Treatment) 03/2013